Navigation Links
Sinovac Reports Unaudited Third Quarter 2009 Financial Results
Date:11/15/2009

1,443,834 811,901 2,753,009 2,408,745 $133,176 (2008- $16,829) for three months and $261,861 (2008- $147,958) for nine months in government research grants Depreciation of property, plant and equipment and amortization of licenses and permits 179,962 178,404 511,835 526,117 Total operating expenses 5,143,773 4,782,221 15,192,723 16,343,314 Operating income 12,405,217 2,312,588 23,730,137 12,473,120 Interest and financing expenses (246,036) (189,935) (571,349) (747,496) Interest income and other income (expenses) 77,300 58,456 243,451 (36,685) Income before income taxes and non-controlling interest 12,236,481 2,181,109 23,402,239 11,688,939 Income taxes recovery (expense) - Current (3,230,985) (1,005,174) (5,026,902) (4,229,613) - Deferred (551,478) 94,028 (1,399,428) 991,461 Consolidated net income for the period 8,454,018 1,269,963 16,975,909 8,450,787 Less: net income attributable to non-controlling interest (3,228,659) (530,084) (5,917,215) (2,814,703) Net income attributable to the stockholders $5,225,359 $739,879 $11,058,694 $5,636,084 Net income for the period $8,454,018 1,269,963 16,975,909 8,450,787 Other comprehensive income Foreign currency translation adjustment 64,108 33,637 90,728 2,358,956 Total comprehensive income 8,518,126 1,303,600 17,066,637 10,809,743 Less: comprehensive income attributable to non-controlling interest 3,229,599 522,960 5,9
'/>"/>
SOURCE Sinovac Biotech Co., Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Sinovac Obtains Third H1N1 Vaccine Order from Chinese Central Government
2. Sinovac Receives Certificate of Approval to Distribute Panflu (H5N1) Vaccine in Hong Kong
3. Sinovac to Present at 2009 UBS Global Life Sciences Conference
4. Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine
5. Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government
6. Sinovac Obtains Production License for H1N1 Vaccine
7. Sinovac to Host Conference Call to Report 2009 Second Quarter Financial Results
8. Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
9. Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
10. Sinovac Initiates Dosing in Human Clinical Trial of Panflu for Pandemic Influenza A (H1N1)
11. Sinovac Adjourns 2008 Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)...   SurePure, Inc . (OTCQB: SURP), a ... the Company has completed the verification process and ... ("SURP") securities on OTCQB, an electronic quote and ... stage companies. On March 26, 2014, ... designed to improve marketplace integrity and enhance transparency ...
(Date:3/27/2015)... 27, 2015 WuXi PharmaTech (Cayman) Inc. ... capability and technology platform company serving the global ... that an Investigational New Drug (IND) application for ... arthritis has been accepted for review by the ... In September 2012, MedImmune, the global biologics ...
(Date:3/26/2015)... 26, 2015  Roka Bioscience, Inc. (NASDAQ: ... providing advanced testing solutions for the detection of ... the three months and full year ended December ... Results:Revenue for the quarter ended December 31, 2014 ... fourth quarter of 2013 and $1.5 million for ...
(Date:3/26/2015)... CO (PRWEB) March 26, 2015 The ... has formed a strategic alliance with Designing Gig LLC ... their clients. , “Forging this alliance with ... Now we can extend a comprehensive, end-to-end, digital ... development, strategy, and execution,” said Chuck Miller, president of ...
Breaking Biology Technology:SurePure Completes Verification and Approved for Trading on the OTCQB Marketplace 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 2Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 4Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 5Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 6Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 7The Market Element LLC and Designing Gig LLC Form Strategic Alliance 2
... , PURCHASE, N.Y., Oct. 15 Nutrition 21, Inc. ... nutritional supplements under the Iceland Health®, Chromax® and Diabetes ... improve cardiovascular health, enhance memory and reduce chronic joint ... and the full fiscal year ended June 30, 2009. ...
... MedImmune today announced that researchers will present data on ... the American College of Rheumatology, from October 17 to ... Pennsylvania. , "Through our research into novel disease ... our mission of using scientific excellence to deliver life-changing ...
... Today, Formatech, Inc. announced that GeoVax Labs, Inc.,s ... the first clinical candidate that is formulated and filled under ... be completed in January 2010. Under this program, Formatech ... one lot of the vaccine for use in support of ...
Cached Biology Technology:Nutrition 21 Announces Financial Results for Q4 of Fiscal 2009 and Full Year Fiscal 2009 2Nutrition 21 Announces Financial Results for Q4 of Fiscal 2009 and Full Year Fiscal 2009 3Nutrition 21 Announces Financial Results for Q4 of Fiscal 2009 and Full Year Fiscal 2009 4Nutrition 21 Announces Financial Results for Q4 of Fiscal 2009 and Full Year Fiscal 2009 5Nutrition 21 Announces Financial Results for Q4 of Fiscal 2009 and Full Year Fiscal 2009 6MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology 2MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology 3Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its 'Fillanthropy(TM) Program' 2Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its 'Fillanthropy(TM) Program' 3Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its 'Fillanthropy(TM) Program' 4
(Date:3/20/2015)... 19, 2015 Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ... - Global Strategic Business Report" report to their offering. ... Biometrics in US$ Thousands. The report provides separate comprehensive analytics ... Japan , Europe , ... Latin America . Annual estimates ...
(Date:3/17/2015)... NEW YORK , March 17, 2015 /PRNewswire/ ... , the largest exhibition for service robots ever ... . RoboUniverse takes place on May 11-13, 2015 ... Sponsors and exhibitors for the event include: Acorn ... Motion Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic ...
(Date:3/12/2015)... Calif. , March 12, 2015 WHEN:Tuesday, ... Complimentary Registration here: http://bit.ly/1G7Os0L . SPEAKERS: , ... Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... order to compete in several different markets and ... is currently witnessing an uptrend. ...
Breaking Biology News(10 mins):Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
... President Barack Obama called for in his address to the ... other companies be responsible to both their shareholders and society, ... School of Business. The rigorous survey-based nationwide study ... Gulf of Mexico found that Republicans, Democrats and Independents strongly ...
... Researchers at the University of Cincinnati have received a ... influenza virus. An interdisciplinary team of scientists has ... Institute for Allergy and Infectious Diseases, one of the ... grant is "Glycan Receptor Mimics for Rapid Detection, Typing, ...
... WASHINGTON, DC (June 15, 2010) Today, the ... the Secretary,s Advisory Committee on Genetics, Health and Society ... anticipation of advances in sequencing and its incorporation into ... for the Committee,s consideration. "In the next ...
Cached Biology News:Consumer responses to Gulf oil spill reflect Americans' changing corporate expectations 2Team of UC scientists awarded $2 million NIH grant for better flu diagnoses 2AMP commends SACGHS whole genome sequencing focus, raises ethical questions and forms working group 2AMP commends SACGHS whole genome sequencing focus, raises ethical questions and forms working group 3
... leader in electroporation products and specialty electrodes, ... line for experiment optimization and large volume ... breakthrough in Molecular Delivery. The days of ... typically limited the number of samples and ...
... Endogens Screening Sets contain the ... develop five colorimetric sandwich ELISA plates ... in 100 l/well of cell culture ... and Detection Antibodies, Recombinant Standard (5 ...
... Competitor Assay Kits are ideal for ... binding compounds using fluorescence polarization (FP). ... of glutathione transferase to the ligand ... [PR-LBD(GST)] and a proprietary, fluorescently tagged ...
... The organic acid analysis standard ... six organic salts; molecular weights ... This standard is provided for ... column and the organic acid ...
Biology Products: